Union for International Cancer Control (UICC)

About us
Spotlight on
Logo for UICC's let's talk cancer podcast, a globe wearing headphones
Read more
A multi-ethnic group of women standing around smiling
Read more
Lebanese cancer foundation - woman kneading dough
Read more
A group of women of different ages and ethnicities with arms over shoulders and smiling
Read more
Logo for UICC's let's talk cancer podcast, a globe wearing headphones
Read more
Earthquake scene in Hatay, Iskenderun, Turkey, 6 February 2023.
Read more
Displaced people in Ukraine
Read more

Leading the global fight against cancer




UICC provides learning and development opportunities for members. Member organisations have privileged access to UICC events and voting rights as part of the General Assembly.

UICC fosters a learning culture across the cancer community, encourages collaboration and offers a range of knowledge sharing opportunities.

Uniting cancer professionals and policy makers in premier events like the World Cancer Congress and World Cancer Leaders’ Summit is an essential part of UICC’s work. UICC also leads on the global World Cancer Day campaign. 

People shaking hands at the World Cancer Congress 2022

Political will and a national strategy that prioritises targeted investments in cancer control as well as action at the international level can reduce the global cancer burden. 

Anil D'Cruz, now UICC's Immediate-Past-President launching the ATOM Coalition in May 2022

UICC has created several new organisations and initiatives to address long-term public health challenges and unmet needs.

Woman examines patient in front of mammography machine

While UICC works on all aspects of cancer control covering all cancer types, the organisation pays special attention to a number of key thematic areas.

Explore more
Caregiver talking to a woman who has just received cancer treatment

What is cancer control?

Cancer control aims to reduce the incidence, morbidity and mortality of cancer and to improve the quality of life of cancer patients in a defined population, through the systematic implementation of evidence-based interventions for prevention, early detection, diagnosis, treatment, and palliative care.

Explore more

News and updates

Fellowship applications suspended

Technician prepares for a viral whole-genome sequencing experiment at the Cancer Genomics Research Laboratory, part of the National Cancer Institute's Division of Cancer Epidemiology and Genetics (DCEG)

How we speak about cancer can save lives

A male and female doctor accompany a woman carrying her young child in hospital ward

Making a difference with data-driven advocacy

Staff of the Indonesian Cancer Information and Support Center Association
Aryanthi Baramuli Putri
View all news and updates

Cancer in the news

Promoting cancer prevention through World Cancer Day in Nigeria

Source: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00692-1/full…

Commercial determinants of health

Source: The Lancet

Women who suffer from mental illnesses have twice the risk of developing cervical cancer

Source: World News Era

Quality of life among patients with cancer and their family caregivers in the Sub-Saharan region: A systematic review of quantitative studies

Source: PLOS Glob Public Health

It Is Time to Close the Gap in Cancer Care

Source: ASCO Post, Editorial by Prof. Jeff Dunn AO, President of UICC

Cancer vaccine research may have reached ‘tipping point’

Source: Healio

Four ways ChatGPT could help level the humanitarian playing field

Source: The New Humanitarian

Synthetic protein tweak could lead to universal cancer immunotherapy

Source: New Atlas

Fighting cancer: when survival depends on geography and education

Source: Ulises

Researchers Chart A Course For Understanding, Preventing, And Treating Young-Onset Colorectal Cancer — ScienceDaily

Source: Science Daily

Featured Resources

Union for International Cancer Control (UICC)
Download (
8.35 MB
About UICC animation thumbnail
Union for International Cancer Control (UICC)
Union for International Cancer Control (UICC)
Download (
628.01 KB
View all resources

Upcoming events

Stay up to date with all the information related to our contributions and to the international events in the field.

See all events

17 April
31 July
Union for International Cancer Control (UICC)
See details
10 May
11 May
Manila , Philippines
Union for International Cancer Control (UICC)
See details


Over 60 partners drive long-term and measurable changes in cancer control for the benefit of the global cancer community.

View all partners

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.

Founded in 1951 to support cancer research, the Swedish Cancer Society is an independent non-profit organization with the vision of finding cures for cancer. The overall aim of the Society is to achieve a higher survival rate and a reduction in the incidence of cancer. Their main task is to raise and distribute money for cancer research. As one of the largest financiers of cancer research in Sweden, the Swedish Cancer Society essentially acts as a national research council. Thanks to the organization’s extensive knowledge about cancer, the Swedish Cancer Society is also active in areas such as public opinion and spreading knowledge about cancer, as well as results of cancer research.

The Dutch Cancer Society is a nation-wide organization for cancer control in the Netherlands. The society was funded in 1949 by Queen Wilhelmina. Her granddaughter, Her Royal Highness Princess Beatrix, is the current patron. The Dutch Cancer Society’s ideal world is one in which nobody dies from cancer ever again. We want fewer people to get cancer, more people to cure, and patients to have a better quality of life, during and after the disease. That’s why we fund and facilitate scientific research, influence policy, and share our knowledge about cancer and its treatment. To make this possible, we raise funds and establish links with other parties involved in cancer control, both here in the Netherlands and elsewhere. The Dutch Cancer Society is entirely dependent on community involvement and donations. Over 100.000 volunteers support the Dutch Cancer Society whether it comes to local or nation-wide fundraising, scientific or policy advice in several councils and committees. We can rely on nearly 1.500 local committees that organize fundraising activities e.g. our annual door-to-door campaign to raise funds for the fight against cancer. The Dutch Cancer Society is supported by over 1 million donors. The Dutch Cancer Society’s office is located in Amsterdam; our professional staff amounts to 198 staff members.

N°1 dermatologist recommended skincare brand worldwide, La Roche-Posay’s mission is to offer life-changing dermatological skincare solutions. Recommended by 90,000 dermatologists worldwide*, La Roche-Posay was created by a pharmacist in 1975. The brand is today present in over 60 countries. It offers a unique range of daily skincare developed for every skin type to complement their dermatological treatments and promote good skincare practices adapted to each skin concern. The brand develops formulas with its exclusive Selenium-rich water, also used at its Thermal Center, the first Dermatology Center in Europe, due to its antioxidant and soothing properties. The products are developed using a strict formulation charter with a minimal number of ingredients and are formulated at optimal concentrations. Additionally, La Roche-Posay products undergo stringent clinical testing for efficacy and safety, even on sensitive skin.  The La Roche-Posay Cancer Support program includes two pillars related to the fight against cancer: Fight With Care to improve patients’ quality of life during all cancer treatment for better adherence and higher chances of healing, and Save Your Skin to prevent skin cancer specifically. On both topics, the brand is committed to raising awareness, training health care professional and the general public, and helping patients by supporting NGOs’ projects beyond skincare. Since 2019, the Fondation La Roche-Posay is also committed to improving the life of children with cancer and their families. In 2020, the brand went a step further in its commitment to protect the planet. Besides launching the first eco-designed tubes integrating cardboard, the brand announced a long-term plan to reduce its use of virgin plastic by 70% in 2025.

For additional information about La Roche-Posay, visit www.laroche-posay.com.

*source: survey on the dermocosmetic market carried out by iqvia and other partners (ipsos, tns) between september 2017 and august 2018 among dermatologists in 62 countries.

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bring forward medicines and vaccines for the world’s most challenging diseases.  MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J., USA. Through their prescription medicines, vaccines, biologic therapies, and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrates their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.

The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. The NCI coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.

Novartis Oncology is a global leader in transforming outcomes for people with cancer. We offer a wide range of innovative therapies to help meet patient needs and have one of the strongest, most productive pipelines in the industry. Our research is driven by a distinctive scientific and clinical strategy focused on precision oncology – understanding how cancer develops on a genomic level and developing drugs that hone in on those targets.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products. We work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims for improving patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide.

Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.

199 days


World Cancer Leaders' Summit 2023

Learn more

310 days


World Cancer Day 2024

Learn more

Are you interested in joining a dynamic network of over 1,200 members?

Become a member

Would you like to support the work of UICC and the cancer community?

Become a partner

Are you organising a cancer-related event and would like to feature it in our events section?

Submit an event